NO20002481D0 - Kombinasjonsterapi for behandling av AIDS - Google Patents

Kombinasjonsterapi for behandling av AIDS

Info

Publication number
NO20002481D0
NO20002481D0 NO20002481A NO20002481A NO20002481D0 NO 20002481 D0 NO20002481 D0 NO 20002481D0 NO 20002481 A NO20002481 A NO 20002481A NO 20002481 A NO20002481 A NO 20002481A NO 20002481 D0 NO20002481 D0 NO 20002481D0
Authority
NO
Norway
Prior art keywords
aids
treatment
combination therapy
therapy
combination
Prior art date
Application number
NO20002481A
Other languages
English (en)
Other versions
NO20002481L (no
Inventor
Joseph P Vacca
Jiunn H Lin
Kuang C Yeh
Jeffrey A Chodakewitz
Paul J Deutsch
William D Ju
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9807938.7A external-priority patent/GB9807938D0/en
Priority claimed from GBGB9819590.2A external-priority patent/GB9819590D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20002481D0 publication Critical patent/NO20002481D0/no
Publication of NO20002481L publication Critical patent/NO20002481L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20002481A 1997-11-13 2000-05-12 Kombinasjonsterapi for behandling av AIDS NO20002481L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6542197P 1997-11-13 1997-11-13
GBGB9807938.7A GB9807938D0 (en) 1998-04-15 1998-04-15 Combination therapy for the treatment of AIDS
US9094098P 1998-06-26 1998-06-26
GBGB9819590.2A GB9819590D0 (en) 1998-09-08 1998-09-08 Combination therapy for the treatment of aids
PCT/US1998/024097 WO1999025352A1 (en) 1997-11-13 1998-11-12 Combination therapy for the treatment of aids

Publications (2)

Publication Number Publication Date
NO20002481D0 true NO20002481D0 (no) 2000-05-12
NO20002481L NO20002481L (no) 2000-07-12

Family

ID=27451773

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002481A NO20002481L (no) 1997-11-13 2000-05-12 Kombinasjonsterapi for behandling av AIDS

Country Status (24)

Country Link
EP (1) EP1044000B1 (no)
JP (1) JP2001522889A (no)
KR (1) KR20010032055A (no)
CN (1) CN1285747A (no)
AR (1) AR013758A1 (no)
AT (1) ATE218866T1 (no)
AU (1) AU749795B2 (no)
BG (1) BG104507A (no)
BR (1) BR9814146A (no)
CA (1) CA2309164A1 (no)
CO (1) CO4970782A1 (no)
DE (1) DE69806062T2 (no)
EA (1) EA200000513A1 (no)
ES (1) ES2177103T3 (no)
HU (1) HUP0100365A3 (no)
ID (1) ID24922A (no)
IL (1) IL135994A0 (no)
IS (1) IS5481A (no)
NO (1) NO20002481L (no)
PE (1) PE20000020A1 (no)
PL (1) PL340430A1 (no)
SK (1) SK6842000A3 (no)
TR (1) TR200001938T2 (no)
WO (1) WO1999025352A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US7462733B2 (en) 2001-07-30 2008-12-09 University Of Southern California Preparation and use of α-keto phosphonates
EA015145B1 (ru) 2003-01-14 2011-06-30 Джилид Сайэнс, Инк. Фармацевтическая композиция и пероральная фармацевтическая дозированная форма (варианты), проявляющие активность в отношении вич-инфекций, лечебный набор и таблетка и способ лечения или предотвращения симптомов или эффектов вич-инфекции
GB2400553A (en) * 2003-04-14 2004-10-20 Cipla Ltd Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT74681A (en) * 1993-12-15 1997-01-28 Merck & Co Inc N-(2-hydroxy-1-indenyl)-2-phenylmethyl-4-hydroxy-5-(2-carboxamido-piperazinyl)-pentaneamide derivatives of hiv protease inhibitor activity and phrmaceutical compositions contining them

Also Published As

Publication number Publication date
NO20002481L (no) 2000-07-12
DE69806062T2 (de) 2003-03-20
DE69806062D1 (de) 2002-07-18
WO1999025352A1 (en) 1999-05-27
EA200000513A1 (ru) 2000-10-30
ES2177103T3 (es) 2002-12-01
PL340430A1 (en) 2001-02-12
PE20000020A1 (es) 2000-01-27
CO4970782A1 (es) 2000-11-07
HUP0100365A3 (en) 2002-06-28
BR9814146A (pt) 2000-10-03
IL135994A0 (en) 2001-05-20
EP1044000B1 (en) 2002-06-12
EP1044000A1 (en) 2000-10-18
CA2309164A1 (en) 1999-05-27
HUP0100365A2 (hu) 2002-05-29
IS5481A (is) 2000-05-09
ATE218866T1 (de) 2002-06-15
KR20010032055A (ko) 2001-04-16
AU749795B2 (en) 2002-07-04
SK6842000A3 (en) 2000-12-11
BG104507A (bg) 2001-03-30
AU1522599A (en) 1999-06-07
CN1285747A (zh) 2001-02-28
TR200001938T2 (tr) 2001-07-23
JP2001522889A (ja) 2001-11-20
AR013758A1 (es) 2001-01-10
ID24922A (id) 2000-08-31

Similar Documents

Publication Publication Date Title
NO991381D0 (no) Kombinasjonsterapi for behandling av psykoser
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
NO986052D0 (no) Antikonvulsive derivater for behandling av fedme
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
ID18679A (id) Penggunaan terapi lanjutan
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
NO20003042L (no) FremgangsmÕte for profylaktisk behandling av mastitt
NO983512D0 (no) Midler for behandling og forhindring av AIDS
NO984432D0 (no) FremgangsmÕte for behandling av migrenesmerte
ID24922A (id) Terapi kombinasi untuk pengobatan aids
NO982562D0 (no) Sammensetning for behandling av smerte
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ZA9810306B (en) Combination therapy for the treatment of aids
NO984190D0 (no) Fremgangsmåte for behandling av insomnia
ID24521A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
FI102961B1 (fi) Menetelmä tuhkan käsittelemiseksi
GB9807938D0 (en) Combination therapy for the treatment of AIDS
GB9819590D0 (en) Combination therapy for the treatment of aids

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application